Abstract
Oxatomide is a very potent inhibitor of histamine release induced by anti-1gE and Timothy pollen extract in passively sensitized human lung fragments and that induced by anti-1gE from human leucocytes. Its spectrum of activity is different from sodium cromoglycate-like drugs.
In high concentrations oxatomide, like other antihistamines and related structures, induced histamine release from both lung and leucocytes. However, oxatomide induced histamine release far more effectively from sensitized lung than non-sensitized lung.
Inhibition of immunologically induced histamine release by oxatomide may play a part in its action as an anti-hay fever and, possibly, an anti-asthmatic drug.
Similar content being viewed by others
References
F. Awouters, C.J.E. Niemegeers, J. Van den Berk, J.M. Van Nueten, F.M. Lenaerts, M. Borgers, K.H.L. Schellekens, A. Broeckaert, J. De Cree andP.A.J. Janssen,Oxatomide, a New Orally Active Drug which Inhibits both the Release and the Effect of Allergic Mediators, Experientia33, 1657–1659 (1977).
M. Borgers, M. De Brabander, J. Van Reempts, F. Awouters andP.A.J. Janssen,Morphological Evaluation of Oxatomide — a New Anti-Allergic Compound in Guinea-Pig Anaphylaxis, Int. Archs Allergy appl. Immun.56, 507–516 (1978).
F. De Clerck, L. Van Gorp, O. Vanparijs, M. Borgers andF. Awouters,Oxatomide Protects Trichinella spiralis Infected Mice from Lethal Anaphylaxis, Agents and Action8, 568–571 (1978).
R. De Beule, E. Vannieuwenhuyse, J. Callier, W. Verstraete, F. Degreef, M. Gregoire, Y. Robience, W. Stevens andP. Libert,Double Blind Placebo Controlled Clinical Evaluation of Oxatomide (R35443), a Novel Potent Anti-Allergic Drug in the Treatment of Hay Fever, Acta Allergol.32, 278–289 (1977).
D.P. Evans, J.A. Lewis andD.S. Thomson,An Automated Fluorimetric Assay for the Rapid Determination of Histamine in Biological Fluids, Life Sci.12, 327–336 (1973).
L.M. Lichtenstein andA.G. Osler,Studies on the Mechanism of Hypersensitivity Phenomena: IX, Histamine Release from Human Leukocytes by Ragweed Pollen Antigen, J. exp. Med.120, 507–530 (1964).
T.J. Sharpe, J.W. Ross andB.A. Spicer,The Effect of Sodium 5,6-Dimethyl-2-nitroindandione on Anaphylactic Reactions in vitro, Agents and Actions8, 199–202 (1978).
J. Augstein, H. Cairns, D. Hunter, T.B. Lee, J. Suschitsky, R.E.C. Altounyan, D.M. Jackson, J. Mann, T.S.C. Orr andP. Sheard,New Orally Effective Chromone Derivatives for the Treatment of Asthma, Agents and Actions7, 433–455 (1977).
M.K. Church,Chromoglycate-like Anti-Allergic Drugs: A Review, Drugs of Today14, 281–341 (1978).
M.K. Church andC.F. Gradidge,The Activity of Sodium Cromoglycate Analogues in Human Lung in vitro: A Comparison with Rat PCA and Clinical Efficacy, Br. J. Pharmac., In press.
M.K. Church andC.F. Gradidge,Inhibition of Histamine Release from Human Lung in vitro by Anti-Histamines and Related Drugs Br. J. Pharmac., In press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Church, M.K., Gradidge, C.F. Oxatomide: Inhibition and stimulation of histamine release from human lung and leucocytes in vitro. Agents and Actions 10, 4–7 (1980). https://doi.org/10.1007/BF02024171
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02024171